Patient adherence improves glycemic control

Mary K. Rhee, Wrenn Slocum, David C. Ziemer, Steven D. Culler, Curtiss B. Cook, Imad M. El-Kebbi, Daniel L. Gallina, Catherine Barnes, Lawrence S. Phillips

Research output: Contribution to journalArticle

223 Citations (Scopus)

Abstract

Purpose: The purpose of this study was to assess the influence of appointment keeping and medication adherence on HbA1c. Methods: A retrospective evaluation was performed in 1560 patients with type 2 diabetes who presented for a new visit to the Grady Diabetes Clinic between 1991 and 2001 and returned for a follow-up visit and HbA1c after 1 year of care. Appointment keeping was assessed by the number of scheduled intervening visits that were kept, and medication adherence was assessed by the percentage of visits in which self-reported diabetes medication use was as recommended at the preceding visit. Results: The patients had an average age of 55 years, body mass index (BMI) of 32 kg/m2, diabetes duration of 4.6 years, and baseline HbA1c of 9.1%. Ninety percent were African American, and 63% were female. Those who kept more intervening appointments had lower HbA1c levels after 12 months of care (7.6% with 6-7 intervening visits vs 9.7% with O intervening visits). Better medication adherence was also associated with lower HbA1c levels after 12 months of care (7.8% with 76%-100% adherence). After adjusting for age, gender, race, BMI, diabetes duration, and diabetes therapy in multivariate linear regression analysis, the benefits of appointment keeping and medication adherence remained significant and contributed independently; the HbA1c was 0.12% lower for every additional intervening appointment that was kept (P = .0001) and 0.34% lower for each quartile of better medication adherence (P = .0009). Conclusion: Keeping more appointments and taking diabetes medications as directed were associated with substantial improvements in HbA1c. Efforts to enhance glycemic outcomes should include emphasis on these simple but critically important aspects of patient adherence.

Original languageEnglish (US)
Pages (from-to)240-250
Number of pages11
JournalDiabetes Educator
Volume31
Issue number2
DOIs
StatePublished - Mar 2005
Externally publishedYes

Fingerprint

Patient Compliance
Medication Adherence
Appointments and Schedules
Body Mass Index
African Americans
Type 2 Diabetes Mellitus
Linear Models
Regression Analysis

ASJC Scopus subject areas

  • Internal Medicine
  • Public Health, Environmental and Occupational Health
  • Endocrinology, Diabetes and Metabolism

Cite this

Rhee, M. K., Slocum, W., Ziemer, D. C., Culler, S. D., Cook, C. B., El-Kebbi, I. M., ... Phillips, L. S. (2005). Patient adherence improves glycemic control. Diabetes Educator, 31(2), 240-250. https://doi.org/10.1177/0145721705274927

Patient adherence improves glycemic control. / Rhee, Mary K.; Slocum, Wrenn; Ziemer, David C.; Culler, Steven D.; Cook, Curtiss B.; El-Kebbi, Imad M.; Gallina, Daniel L.; Barnes, Catherine; Phillips, Lawrence S.

In: Diabetes Educator, Vol. 31, No. 2, 03.2005, p. 240-250.

Research output: Contribution to journalArticle

Rhee, MK, Slocum, W, Ziemer, DC, Culler, SD, Cook, CB, El-Kebbi, IM, Gallina, DL, Barnes, C & Phillips, LS 2005, 'Patient adherence improves glycemic control', Diabetes Educator, vol. 31, no. 2, pp. 240-250. https://doi.org/10.1177/0145721705274927
Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, El-Kebbi IM et al. Patient adherence improves glycemic control. Diabetes Educator. 2005 Mar;31(2):240-250. https://doi.org/10.1177/0145721705274927
Rhee, Mary K. ; Slocum, Wrenn ; Ziemer, David C. ; Culler, Steven D. ; Cook, Curtiss B. ; El-Kebbi, Imad M. ; Gallina, Daniel L. ; Barnes, Catherine ; Phillips, Lawrence S. / Patient adherence improves glycemic control. In: Diabetes Educator. 2005 ; Vol. 31, No. 2. pp. 240-250.
@article{0ce82c10372b442baf920dc46d34c5ff,
title = "Patient adherence improves glycemic control",
abstract = "Purpose: The purpose of this study was to assess the influence of appointment keeping and medication adherence on HbA1c. Methods: A retrospective evaluation was performed in 1560 patients with type 2 diabetes who presented for a new visit to the Grady Diabetes Clinic between 1991 and 2001 and returned for a follow-up visit and HbA1c after 1 year of care. Appointment keeping was assessed by the number of scheduled intervening visits that were kept, and medication adherence was assessed by the percentage of visits in which self-reported diabetes medication use was as recommended at the preceding visit. Results: The patients had an average age of 55 years, body mass index (BMI) of 32 kg/m2, diabetes duration of 4.6 years, and baseline HbA1c of 9.1{\%}. Ninety percent were African American, and 63{\%} were female. Those who kept more intervening appointments had lower HbA1c levels after 12 months of care (7.6{\%} with 6-7 intervening visits vs 9.7{\%} with O intervening visits). Better medication adherence was also associated with lower HbA1c levels after 12 months of care (7.8{\%} with 76{\%}-100{\%} adherence). After adjusting for age, gender, race, BMI, diabetes duration, and diabetes therapy in multivariate linear regression analysis, the benefits of appointment keeping and medication adherence remained significant and contributed independently; the HbA1c was 0.12{\%} lower for every additional intervening appointment that was kept (P = .0001) and 0.34{\%} lower for each quartile of better medication adherence (P = .0009). Conclusion: Keeping more appointments and taking diabetes medications as directed were associated with substantial improvements in HbA1c. Efforts to enhance glycemic outcomes should include emphasis on these simple but critically important aspects of patient adherence.",
author = "Rhee, {Mary K.} and Wrenn Slocum and Ziemer, {David C.} and Culler, {Steven D.} and Cook, {Curtiss B.} and El-Kebbi, {Imad M.} and Gallina, {Daniel L.} and Catherine Barnes and Phillips, {Lawrence S.}",
year = "2005",
month = "3",
doi = "10.1177/0145721705274927",
language = "English (US)",
volume = "31",
pages = "240--250",
journal = "The Diabetes educator",
issn = "0145-7217",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Patient adherence improves glycemic control

AU - Rhee, Mary K.

AU - Slocum, Wrenn

AU - Ziemer, David C.

AU - Culler, Steven D.

AU - Cook, Curtiss B.

AU - El-Kebbi, Imad M.

AU - Gallina, Daniel L.

AU - Barnes, Catherine

AU - Phillips, Lawrence S.

PY - 2005/3

Y1 - 2005/3

N2 - Purpose: The purpose of this study was to assess the influence of appointment keeping and medication adherence on HbA1c. Methods: A retrospective evaluation was performed in 1560 patients with type 2 diabetes who presented for a new visit to the Grady Diabetes Clinic between 1991 and 2001 and returned for a follow-up visit and HbA1c after 1 year of care. Appointment keeping was assessed by the number of scheduled intervening visits that were kept, and medication adherence was assessed by the percentage of visits in which self-reported diabetes medication use was as recommended at the preceding visit. Results: The patients had an average age of 55 years, body mass index (BMI) of 32 kg/m2, diabetes duration of 4.6 years, and baseline HbA1c of 9.1%. Ninety percent were African American, and 63% were female. Those who kept more intervening appointments had lower HbA1c levels after 12 months of care (7.6% with 6-7 intervening visits vs 9.7% with O intervening visits). Better medication adherence was also associated with lower HbA1c levels after 12 months of care (7.8% with 76%-100% adherence). After adjusting for age, gender, race, BMI, diabetes duration, and diabetes therapy in multivariate linear regression analysis, the benefits of appointment keeping and medication adherence remained significant and contributed independently; the HbA1c was 0.12% lower for every additional intervening appointment that was kept (P = .0001) and 0.34% lower for each quartile of better medication adherence (P = .0009). Conclusion: Keeping more appointments and taking diabetes medications as directed were associated with substantial improvements in HbA1c. Efforts to enhance glycemic outcomes should include emphasis on these simple but critically important aspects of patient adherence.

AB - Purpose: The purpose of this study was to assess the influence of appointment keeping and medication adherence on HbA1c. Methods: A retrospective evaluation was performed in 1560 patients with type 2 diabetes who presented for a new visit to the Grady Diabetes Clinic between 1991 and 2001 and returned for a follow-up visit and HbA1c after 1 year of care. Appointment keeping was assessed by the number of scheduled intervening visits that were kept, and medication adherence was assessed by the percentage of visits in which self-reported diabetes medication use was as recommended at the preceding visit. Results: The patients had an average age of 55 years, body mass index (BMI) of 32 kg/m2, diabetes duration of 4.6 years, and baseline HbA1c of 9.1%. Ninety percent were African American, and 63% were female. Those who kept more intervening appointments had lower HbA1c levels after 12 months of care (7.6% with 6-7 intervening visits vs 9.7% with O intervening visits). Better medication adherence was also associated with lower HbA1c levels after 12 months of care (7.8% with 76%-100% adherence). After adjusting for age, gender, race, BMI, diabetes duration, and diabetes therapy in multivariate linear regression analysis, the benefits of appointment keeping and medication adherence remained significant and contributed independently; the HbA1c was 0.12% lower for every additional intervening appointment that was kept (P = .0001) and 0.34% lower for each quartile of better medication adherence (P = .0009). Conclusion: Keeping more appointments and taking diabetes medications as directed were associated with substantial improvements in HbA1c. Efforts to enhance glycemic outcomes should include emphasis on these simple but critically important aspects of patient adherence.

UR - http://www.scopus.com/inward/record.url?scp=17244366106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17244366106&partnerID=8YFLogxK

U2 - 10.1177/0145721705274927

DO - 10.1177/0145721705274927

M3 - Article

C2 - 15797853

AN - SCOPUS:17244366106

VL - 31

SP - 240

EP - 250

JO - The Diabetes educator

JF - The Diabetes educator

SN - 0145-7217

IS - 2

ER -